EGFR and lung carcinoma: Several studies have emerged using radiomics as a “virtual biopsy” for EGFR mutation status in lung cancer patients, showing moderate performance in the prediction of EGFR mutation status with AUC values ranging between 0.75 and 0.9595–97 (Table 3).